Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma.

导出 OA

翻译打印收藏纠错

第一作者： Fouad,Choueiry

第一单位： Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA.

作者： Fouad,Choueiry ^[1] ; Satishkumar,Singh ^[2] ; Anuvrat,Sircar ^[3] ; Georgios,Laliotis ^[2] ; Xiaowei,Sun ^[3] ; Evangelia,Chavdoula ^[3] ; Shiqi,Zhang ^[4] ; JoBeth,Helmig-Mason ^[1] ; Amber,Hart ^[3] ; Narendranath,Epperla ^[4] ; Philip,Tsichlis ^[1] ; Robert,Baiocchi ^[2] ; Lapo,Alinari ^[2] ; Jiangjiang,Zhu ^[2] ; Lalit,Sehgal ^[3]

作者单位： Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA. ^[1] Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA. ^[2] James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. ^[3] Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210, USA. ^[4]

关键词 DLBCL amino-acid metabolism drug resistance ibrutinib lymphoma metabolic reprogramming metabolomics transcriptomic

DOI 10.3390/cancers13092146

PMID 33946867

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交